MG
LICN icon

Marex Group’s Lichen China LICN Stock Holding History

Marex Group’s Portfolio LICN Stock Details LICN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-618
Closed -$224K – 766
2024
Q3 		$224K Hold
618
– – 0.01% 450
2024
Q2 		$179K Buy
+618
New +$159K ﹤0.01% 523

Other funds holding LICN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Marex Group's LICN Position: Q4 2024 in Review

Marex Group sold out of Lichen China (LICN) in Q4 2024, closing a stake of 618 shares — an estimated $224K sold.

Marex Group first reported a position in LICN in Q2 2024 and held it in 2 quarters. The position peaked at $224K in Q3 2024. 7 funds tracked by Wall St. Rank hold LICN as of Q4 2024.

  • Marex Group reported no remaining Lichen China position as of Q4 2024 after selling out during the quarter.
  • Marex Group sold 618 Lichen China shares in Q4 2024, an estimated $224K.
  • Marex Group first reported a position in Lichen China in Q2 2024 and held it in 2 quarters.
  • Marex Group's Lichen China position peaked at $224K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Lichen China as of Q4 2024.

Based on Marex Group's 13F filing for Q4 2024, filed 2 Apr 2026.